Intermediate-dose anticoagulation, aspirin, and in-hospital mortality in COVID-19: a propensity score-matched analysis

BACKGROUND: Thrombotic complications occur at high rates in hospitalized patients with COVID-19, yet the impact of intensive antithrombotic therapy on mortality is uncertain. RESEARCH QUESTION: How does in-hospital mortality compare with intermediate- versus prophylactic-dose anticoagulation, and se...

Descripción completa

Detalles Bibliográficos
Autores principales: Meizlish, Matthew L., Goshua, George, Liu, Yiwen, Fine, Rebecca, Amin, Kejal, Chang, Eric, DeFilippo, Nicholas, Keating, Craig, Liu, Yuxin, Mankbadi, Michael, McManus, Dayna, Wang, Stephen, Price, Christina, Bona, Robert D., Chaar, Cassius Iyad Ochoa, Chun, Hyung J., Pine, Alexander B., Rinder, Henry M., Siner, Jonathan, Neuberg, Donna S., Owusu, Kent A., Lee, Alfred Ian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cold Spring Harbor Laboratory 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7814841/
https://www.ncbi.nlm.nih.gov/pubmed/33469595
http://dx.doi.org/10.1101/2021.01.12.21249577

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7814841/
https://www.ncbi.nlm.nih.gov/pubmed/33469595
http://dx.doi.org/10.1101/2021.01.12.21249577

Ejemplares similares